The Russian government decided to provide a subsidy from the federal budget to NPO Microgen for the reconstruction and technical re-equipment of its production facilities for influenza vaccines in 2018-2021.
In January - May 2018, Nacimbio, a pharmaceutical holding company of Rostec Corporation, has supplied to all regions of Russia more than 1 million doses of vaccines for prevention of tick-borne encephalitis (TBE).
Sanofi, a leading global pharmaceutical company, is investing €350 million for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario.
The representatives of the Public Health Institute of Chile visited a vaccine production facility of St. Petersburg Institute of Vaccines and Serums in order to continue and expand cooperation between Russia and Chile.
In 2017, the revenue of Nanolek LLC reached 2.6 billion rubles, which is a 3-fold increase compared to 2016. The output of medicinal products at the Nanolek plant in the Kirov region amounted to 8.1 million packages.